Endocannabinoids and vascular function

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 1, 2000, Pages 27-32

  Hillard, Cecilia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; BENZOPYRAN DERIVATIVE; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; DEXANABINOL; DRONABINOL; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; G PROTEIN COUPLED RECEPTOR; RIMONABANT;

ANTIHYPERTENSIVE ACTIVITY; BLOOD VESSEL FUNCTION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMPATHETIC NERVE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; ENDOTHELIUM, VASCULAR; GLYCERIDES; HUMANS; MUSCLE, SMOOTH, VASCULAR; NEURONS, AFFERENT; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0033917648     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG and Makriyannis A (1994) (R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37:1889-1893.
2. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L and Di Marzo V (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322: 671-677.
3. Chaytor AT, Martin PE, Evans WH, Randall MD and Griffith TM (1999) The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol (Lond) 520:539-550.
4. Deutsch D, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HHO, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G and Moore LC (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100:1538-1546.
5. Devane WA, Hanus L, A. Breuer, RG Pertwee, LA Stevenson, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
6. Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151-178.
7. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA and Kunos G (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264:258-267.
8. Di Marzo V, De Petrocellis L, Sepe N and Buono A (1996) Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J 316:977-984.
9. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC and Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (Lond) 372:686-691.
10. Dutta AK, Sard H, Ryan W, Razdan RK, Compton DR and Martin BR (1994) The synthesis and pharmacological evaluation of the cannabinoid antagonist SR141716A. Med Chem Res 5:54-62.
11. Edgemond WS, Hillard CJ, Falck JR, Kearn CS and Campbell WB (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): Their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol 54:180-188.
12. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA and Brownstein M (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284: 291-297.
13. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfmger TV and Stefano GB (1999) Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: Coupling to nitric oxide release. Cell Signal 11:189-193.
14. 2+ channel current. Am J Physiol 276:H2085-H2093.
15. Hardman HF, Domino EF and Seevers MH (1971) General pharmacological actions of some synthetic tetrahydrocannabinol derivatives. Pharmocol Rev 23:295-315.
16. Hillard CJ and Campbell WB (1997) Biochemistry and pharmacology of arachidonylethanolamine, a putative endogenous cannabinoid. J Lipid Res 38:2383-2398.
17. o to the inhibition of adenylyl cyclase in carotid artery smooth muscle. Br J Pharmacol 128:597-604.
18. 1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028.
19. 2+ -induced relaxation. J Pharmacol Exp Ther 289:245-250.
20. 2 receptors. Proc Natl Acad Sci USA 96:14136-14141.
21. 1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030-1037.
22. Mathew R and Wilson W (1993) Acute changes in cerebral blood flow after smoking marijuana. Life Sci 52:757-767.
23. 2+ in endothelial cells. Br J Pharmacol 126:1593-1600.
24. Niederhoffer N and Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126:457-466.
25. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635-664.
26. Pestonjamasp VK and Burstein SH (1998) Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim Biophys Acta 1394:249-260.
27. Plane F, Holland M, Waldron GJ, Garland CJ and Boyle JP (1997) Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 121:1509-1511.
28. 1 cannabinoid receptor. Am J Physiol 274:H375-H381.
29. Randall MD, Alexander SPH, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI and Kendall DA (1996) An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Comm 229:114-120.
30. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinex S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere JC and LeFur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
31. Shen MX, Piser TM, Seybold VS and Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
32. Stella N, Schweitzer P and Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature (Lond) 388:773-778.
33. 2+ transient in NG108-15 cells. J Biochem (Tokyo) 122:890-895.
34. 1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 243:838-843.
35. 1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem 274:2794-2801.
36. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279-283.
37. Varga K, Lake KD, Huangfu D, Guyenet PG and Kunos G (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28:682-686.
38. Varga K, Wagner JA, Bridgen DT and Kunos G (1998) Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12:1035-1044.
39. Vollmer R, Cavero I, Ertel R, Solomon T and Buckley J (1974) Role of the central autonomie nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol 26:186-192.
40. 1 cannabinoid receptors in haemorrhagic shock. Nature (Lond) 390:518-521.
41. Wagner JA, Varga K, Jarai Z and Kunos G (1999) Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33:429-434.
42. White R and Hiley CR (1997) A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 122: 1573-1584.
43. 1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785.
44. Zygmunt PM, Hogestatt ED, Waldeck K, Edwards G, Kirkup AJ and Weston AH (1997) Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacol 122:1679-1686.
45. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D and Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-457.